Global Cell Therapy Market to Grow at a CAGR of 7% During 2021-2026, Aided by Increasing Investment in Healthcare Sector

The market is being driven by the increasing research and development (R&D) activities in the medical sector. The COVID-19 pandemic is expected to accelerate pharmaceutical and biotechnological based research projects, including cell therapy. Since the deadly virus critically damages the lungs and immune system of the infected patient, various cell therapies are increasingly being explored as a potential treatment for the novel disease, thus augmenting market growth. The development of effective treatment of solid tumours is likely to be another breakthrough for the cell therapy industry. The potential for cell therapy to treat major diseases, such as anaemia, cancer, and Alzheimer’s disease, among others, is projected to further strengthen the cell therapy industry in the forecast period.

Tego Science Inc (KOSDAQ: 191420) is a leading pharmaceutical company based in South Korea. The company holds a significant share in the market of cell therapy. Based on recent updates, the company completed the enrolment of patients for a phase-3 trial of TPX-114, which is an autologous cell therapy that has greater prospects for the cell therapy industry. The therapy treats full-thickness rotator cuff tear using the patient’s tissue. The constant research and development in the field of cell therapy is propelling the growth of the market. The demand for rotator cuff tear is rapidly rising owing to the ageing population and increasing sports activities, which is adding to the overall growth of the cell therapy market.

Market Analysis by Type, Therapy, Application, and Region:

• On the basis of type, the market is divided into autologous and allogeneic.
• Based on therapy, the market is segmented into mesenchymal stem cell therapy, fibroblast cell therapy, and haematopoietic stem cell therapy.
• The market on the basis of application is divided into musculoskeletal, malignancies, cardiovascular, and dermatology and wounds.
• The major regional markets for cell therapy are North America, Latin America, Europe, the Asia Pacific, and the Middle East and Africa.

Key Finding of the Report:

• The cell therapy industry is driven by growing innovations in the treatment of cancer, solid tumours, and weakened immune systems, among other diseases.
• Cell therapy can substantially improve survival rates of end-stage patients with acute respiratory distress syndrome (ARSD) associated with SARS-CoV-2, which is providing further impetus to the industry growth.
• Favourable government initiatives are contributing to innovations in cell therapy, thereby boosting the market growth.
• Cell therapies are becoming an ideal choice of treatment because of their excellent success rates, further boosting the market growth.

Key Offerings of the Report:

• The EMR report gives an overview of the global market for cell therapy for the periods (2016-2020) and (2021-2026).
• The report also offers the historical (2016-2020) and forecast (2021-2026) markets for the types, therapies, applications, and major regions of cell therapy.
• The report analyses the market dynamics, covering the key demand and price indicators in the market, along with an assessment of the SWOT and Porter’s Five Forces models.

The major players in the global cell therapy market are Tego Science, Chiesi Farmaceutici S.p.A, and Pharmicell Co., Ltd, among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.